Organization · Venture Capital
Proxima Ventures
Proxima Ventures is a Shanghai-based venture capital firm focused on investing in and supporting the development of next-generation healthcare companies. It specializes in innovative technologies that improve public health.
Overview
What Proxima Ventures does
What Proxima Ventures is
Proxima Ventures is a Shanghai-based venture capital firm focused on investing in and supporting the development of next-generation healthcare companies. It specializes in innovative technologies that improve public health.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Proxima Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Proxima Ventures as a funder
Investment thesis
Proxima Ventures specializes in investing in and supporting the development of next-generation healthcare companies, focusing on innovative technologies that can improve public health.
Focus narrative
Proxima Ventures invests in healthcare companies at various stages, from seed to growth. The firm is particularly interested in biotech, medtech, diagnostics, pharmaceuticals, and healthcare services, seeking to back enterprises that demonstrate a potential for significant clinical or public health impact.
Value beyond capital
Proxima Ventures adds value to its portfolio companies by leveraging its extensive network of industry partners and hospital relationships, providing support in areas such as technology development, market access, and strategic guidance.
Focus and fit
- Stages
- Angel · Seed · Series A · Growth Equity
- Sectors
- Healthcare · Biotech · Diagnostics
- Regions
- Global · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Rapafusyn Pharmaceuticals: A Baltimore-based company focused on non-degrading molecular glue therapeutics. Bioelectronica: A biotechnology firm developing digital tools for drug discovery and cell sorting. BridGene Biosciences: Engaged in small-molecule drug discovery. VerImmune: A healthcare/biotech company. iView Therapeutics: A healthcare-focused portfolio company. EpiBone: Specializes in healthcare solutions. Great Bay Bio: Another healthcare portfolio company. Myrobalan Therapeutics: Focused on therapeutic innovations in healthcare.
Common questions
What to know about Proxima Ventures
Upseed classifies Proxima Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.